Imaging the Serotonin System in OCD Please refer to this study by identifier 4461
Principal Investigator(s) H. Simpson
Purpose
The study’s aim is to examine whether brain serotonin receptors are different in patients with obsessive-compulsive disorder (OCD) than in those without OCD. One of the serotonin receptors will be measured (the 5-HT2A receptor) using an investigational drug and a standard imaging procedure called positron emission tomography (PET). An anatomical picture of the brain using magnetic resonance imaging (MRI) is also done. Subjects are compensated $400 for their participation and offered three months of OCD treatment at no cost to them.
Type of Study: Clinical Trial Setting of Study: outpatient Clinical Trials.gov number: Providing Clinical Treatment?: Yes No Cost Treatment?: Yes
Study Activities
Filling Out Forms Blood Samples PET Scan MRI Scan Provides Payment: Compensation for study related procedures
Eligibility
Ages Eligible for Study: 18 Years - 55 Years Genders Eligible for Study: Both
This study is recruiting Healthy Volunteers.
Criteria
Inclusion Criteria: 18-55 years
OCD is the primary problem.
